Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Caroline P. Martens"'
Autor:
Matthias M. Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P. Martens, Valérie Spalart, Anna Ockerman, Caroline Devooght, Joost Wauters, Jan Gunst, Carine Wouters, Christophe Vandenbriele, Steffen Rex, Laurens Liesenborghs, Alexander Wilmer, Philippe Meersseman, Greet Van den Berghe, Dieter Dauwe, Ann Belmans, Michiel Thomeer, Tom Fivez, Dieter Mesotten, David Ruttens, Luc Heytens, Ilse Dapper, Sebastiaan Tuyls, Brecht De Tavernier, Peter Verhamme, Thomas Vanassche, DAWn Consortium Members
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 7, Pp n/a-n/a (2022)
Abstract Background Thromboinflammation plays a central role in severe COVID‐19. The kallikrein pathway activates both inflammatory pathways and contact‐mediated coagulation. We investigated if modulation of the thromboinflammatory response impro
Externí odkaz:
https://doaj.org/article/0b44d597e02c4aa1ae0a47b3c5ef8724
Autor:
Caroline P. Martens, Pierre Van Mol, Joost Wauters, Els Wauters, Tanja Gangnus, Bernard Noppen, Hanne Callewaert, Jean H.M. Feyen, Laurens Liesenborghs, Elisabeth Heylen, Sander Jansen, Leydi Carolina Velásquez Pereira, Sirima Kraisin, Ipek Guler, Matthias M. Engelen, Anna Ockerman, Anke Van Herck, Robin Vos, Christophe Vandenbriele, Philippe Meersseman, Greet Hermans, Alexander Wilmer, Kimberly Martinod, Bjoern B. Burckhardt, Marc Vanhove, Marc Jacquemin, Peter Verhamme, Johan Neyts, Thomas Vanassche
Publikováno v:
EBioMedicine, Vol 83, Iss , Pp 104195- (2022)
Summary: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the angiotensin-converting enzyme 2 (ACE2) receptor, a critical component of the kallikrein-kinin system. Its dysregulation may lead to increased vascular perm
Externí odkaz:
https://doaj.org/article/e22bccf7e13b4f4e9d17aa33606b5009
Autor:
Matthias M. Engelen, Christophe Vandenbriele, Valérie Spalart, Caroline P. Martens, Bert Vandenberk, Pieter Sinonquel, Natalie Lorent, Paul De Munter, Rik Willems, Joost Wauters, Alexander Wilmer, Dieter Dauwe, Jan Gunst, Ipek Guler, Stefan Janssens, Kimberly Martinod, Griet Pieters, Kathelijne Peerlinck, Peter Verhamme, Thomas Vanassche
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Background Venous thromboembolism (VTE) frequently occurs in hospitalized patients with coronavirus disease 2019 (COVID‐19). The optimal dose of anticoagulation for thromboprophylaxis in COVID‐19 is unknown. Aims To report VTE incidence
Externí odkaz:
https://doaj.org/article/2c1238428a3c4e769f7bde88fe726124
Autor:
Severien Meyers, Marleen Lox, Sirima Kraisin, Laurens Liesenborghs, Caroline P. Martens, Liesbeth Frederix, Stijn Van Bruggen, Marilena Crescente, Dominique Missiakas, Pieter Baatsen, Thomas Vanassche, Peter Verhamme, Kimberly Martinod
Background: Infective endocarditis (IE) is characterized by an infected thrombus at the heart valves. How bacteria bypass the immune system and cause these thrombi remains unclear. Neutrophils releasing NETs (neutrophil extracellular traps) lie at th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d077eecaac2c9cd369096c9e21a4e74f
https://lirias.kuleuven.be/handle/20.500.12942/707587
https://lirias.kuleuven.be/handle/20.500.12942/707587
Autor:
Severien, Meyers, Marleen, Lox, Sirima, Kraisin, Laurens, Liesenborghs, Caroline P, Martens, Liesbeth, Frederix, Stijn, Van Bruggen, Marilena, Crescente, Dominique, Missiakas, Pieter, Baatsen, Thomas, Vanassche, Peter, Verhamme, Kimberly, Martinod
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology.
Infective endocarditis (IE) is characterized by an infected thrombus at the heart valves. How bacteria bypass the immune system and cause these thrombi remains unclear. Neutrophils releasing NETs (neutrophil extracellular traps) lie at this interface
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44fd07832577a3fba94a6af3b0513bb0
https://pubmed.ncbi.nlm.nih.gov/36453281
https://pubmed.ncbi.nlm.nih.gov/36453281
Autor:
Ingrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, Fionnuala Ní Áinle, Bernard Tardy, Jennifer Donnelly, Peter Verhamme, Anne F Jacobsen, Anette T Hansen, Marc A Rodger, Maria T DeSancho, Roman G Shmakov, Nick van Es, Martin H Prins, Céline Chauleur, Saskia Middeldorp, Eline S van den Akker, Mireille N Bekker, Thomas van Bemmel, Laurent Bertoletti, Julie Blanc, Suzanne M Bleker, Aude Bourtembourg-Matras, Florence Bretelle, Bridgette Byrne, Francis Couturaud, Pierre Delorme, Elise S Eerenberg, Maureen TM Franssen, Jens Fuglsang, Wessel Ganzevoort, François Goffinet, Jiska M de Haan-Jebbink, Wieteke Heidema, Monique A Hertzberg, Marcel MC Hovens, Menno V Huisman, Leonie de Jong-Speksnijder, Pieter-Willem Kamphuisen, Denis J O'Keeffe, Karine Lacut, Josje Langenveld, M Simone Lunshof, Caroline P Martens, Adel Merah, Emmanuelle Le Moigne, Dimitri NM Papatsonis, Gilles Pernod, Franck Perrotin, Edith Peynaud-Debayle, Fabrice Pierre, Geneviève Plu Bureau, Tiphaine Raia-Barjat, Robbert JP Rijnders, Roger Rosario, Marc Ruivard, Jeannot Schmidt, Marieke Sueters, Thomas Vanassche, Marie-Noëlle Varlet, Alexandre J Vivanti, Matthieu Y van der Vlist, Lucet F van der Voet, Karlijn C Vollebregt, Johanna IP de Vries, Sabina de Weerd, Peter E Westerweel, Lia DE Wijnberger, Marije ten Wolde, Paula F Ypma, Catherine Zuily-Lamy, Joost J Zwart, Alexandra Benachi, Gaël Beucher, Holy Bezanahary, Karin de Boer, Marjon A. de Boer, Frantz Bousquet, Henk A. Bremer, Luc Bressollette, Aurélie Brossard, Cécile Chau, Brian Cleary, Fabienne Comte, Thomas Corsini, Anne Coustel, Barbara Debaveye, Raoul Desbrière, Cécile Duvillard, Astrid Eckman, Jeroen Eikenboom, Antoine Elias, Laura M. Faber, Emile Ferrari, Denis Gallot, Emilie Gauchotte, Ingrid Gaugler, Abby E. Geerlings, Audrey O'Gorman, Vincent Grobost, Pieter-Kees de Groot, David P. van der Ham, Brenda Hermsen, Kim Kamphorst, Alan Karovitch, Gunilla Kleiverda, Aiste Kloster, Annemarieke Koops, Inneke Krabbendam, Marieke J.H.A. Kruip, Saskia Kuipers, Judith van Laar, Damien Laneelle, Suzanne Lima, Peter MacMahon, Laurent Mandelbrot, Claudia A. van Meir, Caroline Menez, Leonard P. Morssink, Nathalie Moulin, Eve Mousty, Matthieu Muller, Lucy Murphy, Kathelijne Peerlinck, Alma O'Reilly, Maartje de Reus, Magali Hilmi Le Roux, Kevin Ryan, Bettina Samren, Daniela Schippers, Nico Schuitemaker, Chloé Schweizer, Hanneke van der Straaten, Cécile Tromeur, Kristine Vanheule, Tamara Verhagen, Jantien Visser, Michael Watts, Wim J. van Wijngaarden, Mallory Woiski, Maartje Zelis
Publikováno v:
The Lancet, 400(10365), 1777-1787. Elsevier Limited
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Item does not contain fulltext BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8643920b0d7863c0bf84cfcc765abbb7
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9